26.08.2019 • Product

Allessan CAP: The versatile and cost saving coupling reagent

Photo

Due to its outstanding properties, it is safe to handle and easy to store. Additionally, using Allessan® CAP will lower your overall process costs, compared to staying with the standard protocol, applying DCC/ HOBt.

Use of coupling reagents for converting carboxylic acids is nowadays widely spread. Specialized coupling reagents, enabling direct condensation of a carboxylic acid moiety and an alcohol or amine, offer a superior direct approach towards highly valuable carboxylic acid derivatives. Among these coupling reagents, Allessan® CAP offers a wide range of benefits.

Apart from its long shelf life (36 months), its high thermal stability (up to 300°C) and its excellent safety profile (no CMR-properties associated), Allessan® CAP proves to be the no. 1 alternative to coupling reagents such as DCC/HOBt, EDC, or CDI.

Being produced in Germany in an ISO9001 & ISO14001 certified facility for more than one decade, no supply chain interruptions due to tightened environmental regulations are to be expected, giving peace of mind to any procurement/supply chain associate.

Besides its outstanding properties, Allessan® CAP offers serious cost savings switching to an alternative protocol (figure 2). This is the case for example for the synthesis of active pharmaceutical ingredients (APIs) using Allessan® CAP (see figure 3).

Possible uses of Allessan® CAP include amidations, esterifications, Swern-type oxidations as substitute for oxalyl dichloride, and as catalyst during Aza-Diels-Adler reactions.

For more information please contact us via intermediates@weylchem.com.

Company

Logo:

WeylChem International GmbH

Alt-Fechenheim 34
60386 Frankfurt
Germany

Company contact







Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read